Home> Products> hospital setting

{ "products": [ { "_id": "6914248e8c1ae64991df6fc2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Paracetamol Infusion ip", "description": "Paracetamol Infusion IP is a sterile, non-pyrogenic, and clear solution of Paracetamol (Acetaminophen) formulated for intravenous administration. It is primarily used for the management of pain and fever when oral or rectal routes are not suitable, such as in hospitalized or post-operative patients. Recognized as one of the most widely used analgesic and antipyretic medications, Paracetamol Infusion IP offers rapid onset of action, consistent therapeutic effects, and excellent patient tolerance.\n\nThis formulation ensures precise and controlled delivery of Paracetamol directly into the bloodstream, allowing for faster relief and improved bioavailability compared to oral administration.\n\nComposition\n\nEach 100 mL of Paracetamol Infusion IP typically contains:\n\nParacetamol IP – 1000 mg (1% w/v)\n\nExcipients – as required for stability and isotonicity\n\nWater for Injection – q.s. to 100 mL\n\nThe infusion is usually supplied in ready-to-use glass or plastic bottles or flexible bags, ensuring sterility and ease of use in hospital settings.\n\nMechanism of Action\n\nParacetamol (acetaminophen) exerts its therapeutic effects primarily through central inhibition of prostaglandin synthesis. Unlike nonsteroidal anti-inflammatory drugs (NSAIDs), Paracetamol has minimal peripheral anti-inflammatory activity, making it a safer option for patients with gastrointestinal or platelet-related concerns.\n\nThe drug acts by:\n\nInhibiting the cyclooxygenase (COX) enzymes, particularly COX-3, within the central nervous system, thereby reducing the synthesis of prostaglandins responsible for fever and pain.\n\nModulating the endocannabinoid system and serotonergic pathways, enhancing its analgesic potential.\n\nAs a result, Paracetamol Infusion IP provides effective fever reduction (antipyretic) and pain relief (analgesic) without significant gastrointestinal irritation or bleeding risks.\n\nIndications and Uses\n\nParacetamol Infusion IP is indicated for:\n\nManagement of Fever (Pyrexia):\n\nReduces elevated body temperature in adults and children.\n\nSuitable for patients unable to take oral medication due to nausea, vomiting, or unconsciousness.\n\nRelief of Mild to Moderate Pain:\n\nEffective in conditions like headaches, dental pain, menstrual cramps, and musculoskeletal pain.\n\nCommonly used as part of multimodal pain management after surgical procedures.\n\nPost-Operative and Trauma Pain:\n\nProvides fast, reliable pain relief in surgical recovery and trauma cases where oral medication is not feasible.\n\nAdjunct Therapy:\n\nCan be used alongside opioids to enhance analgesic effect and reduce opioid requirements.\n\nDosage and Administration\n\nAdults and adolescents (>50 kg): 1 g every 6 hours, not exceeding 4 g per day.\n\nAdults and adolescents (<50 kg): Dose adjusted based on body weight, typically 15 mg/kg every 6 hours.\n\nChildren (≥10 kg): 15 mg/kg per dose every 6 hours.\n\nThe infusion should be administered over 15 minutes, using aseptic technique. Paracetamol Infusion should not be mixed with other drugs in the same IV line unless compatibility is established.\n\nKey Benefits\n\nRapid Onset of Action:\nIntravenous administration ensures faster absorption and onset of relief compared to oral or rectal forms.\n\nHigh Bioavailability:\nSince it bypasses gastrointestinal metabolism, almost the entire dose reaches systemic circulation, providing consistent therapeutic effect.\n\nConvenience in Critical Care:\nIdeal for patients who are unconscious, post-surgery, or unable to tolerate oral medications.\n\nSafe and Well-Tolerated:\nHas minimal gastrointestinal side effects and no significant effect on platelets or renal function when used within the recommended dose range.\n\nEffective Multimodal Pain Relief:\nEnhances pain control when combined with opioids, allowing reduced opioid dosage and minimizing associated risks.\n\nStable Formulation:\nThe isotonic and sterile composition ensures patient safety, stability, and reduced risk of contamination.\n\nSuitable for Broad Patient Demographics:\nCan be used in adults, elderly patients, and children under proper medical supervision.\n\nPrecautions and Warnings\n\nWhile Paracetamol Infusion IP is generally safe, the following precautions should be observed:\n\nLiver Impairment:\nUse with caution in patients with hepatic insufficiency, chronic alcoholism, or pre-existing liver disease, as Paracetamol is primarily metabolized in the liver.\n\nRenal Impairment:\nDosage adjustment may be required in severe renal dysfunction.\n\nAvoid Overdose:\nExceeding the recommended dose can lead to severe liver toxicity and, in extreme cases, hepatic failure.\n\nDrug Interactions:\nConcomitant use with other Paracetamol-containing medications increases risk of overdose.\nCaution when used with hepatotoxic drugs or alcohol.\n\nPregnancy and Lactation:\nGenerally considered safe when used under medical supervision, though benefits should outweigh potential risks.\n\nPossible Side Effects\n\nAlthough rare and usually mild, Paracetamol Infusion IP may cause:\n\nAllergic Reactions:\nSkin rash, itching, urticaria, or swelling.\n\nHypotension:\nA transient drop in blood pressure may occur during infusion in some patients.\n\nLiver Toxicity:\nOverdose or prolonged use can lead to hepatocellular injury or elevated liver enzymes.\n\nInjection Site Reactions:\nMild pain, redness, or inflammation at the infusion site.\n\nBlood Disorders (Very Rare):\nThrombocytopenia or leukopenia may occur in extremely rare cases.\n\nIf any severe reaction such as jaundice, persistent vomiting, or allergic swelling occurs, medical attention should be sought immediately.\n\nStorage and Handling\n\nStore below 30°C, protected from light and freezing.\n\nDo not use if the solution appears cloudy or contains particles.\n\nSingle-use only; discard any unused portion after opening.\n\nConclusion\n\nParacetamol Infusion IP stands as a trusted, fast-acting, and safe intravenous formulation of one of the most widely used analgesic and antipyretic agents worldwide. Its ability to deliver rapid and predictable pain and fever relief makes it invaluable in hospitals, emergency care, and post-surgical settings.\n\nWith its favorable safety profile, high efficacy, and compatibility with multimodal pain management strategies, Paracetamol Infusion IP continues to be a first-line choice for clinicians seeking a reliable and well-tolerated solution for pain and fever management.", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2200, "imageuri": "https://productimages.withfloats.com/actual/6914248ff448eb2e5cf3b164.png", "tileimageuri": "https://productimages.withfloats.com/tile/6914248ff448eb2e5cf3b164.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-12T06:09:18.258Z", "updatedon": "2025-11-12T06:09:18.258Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/paracetamol-infusion-ip/2200", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67122b0ce42a258b4935925e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Pantoprazole (40 mg)", "description": "PANTOSTRUM IV INJECTION is a potent medication designed to manage acid-related disorders. This injectable formulation is particularly useful for patients who require immediate therapeutic intervention, such as those unable to take oral medications. Containing Pantoprazole (40 mg), a powerful proton pump inhibitor (PPI), PANTOSTRUM IV effectively reduces gastric acid secretion, providing relief from conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.\n\nThis product is administered intravenously, ensuring rapid onset of action, which is crucial in managing acute situations where oral administration may not be feasible.\n\n \nKey Benefits: \n \n\nRapid Relief: The intravenous formulation provides quick relief from acid-related symptoms, making it suitable for acute conditions.\n\nEffective for a Range of Conditions: PANTOSTRUM IV is beneficial for treating gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.\n\nPrevents Recurrent Symptoms: Regular use can help prevent the recurrence of acid-related symptoms, improving the quality of life for patients with chronic conditions.\n\nSafe for Short-Term Use: While PPIs are typically used for longer durations, this injectable form is safe for short-term management in a hospital or clinical setting.\n\nWell-Tolerated: Most patients tolerate Pantoprazole well, with a favorable safety profile compared to other PPIs.\n\n \nHow Does It Work?\n \n\nPANTOSTRUM IV INJECTION contains Pantoprazole, which selectively inhibits the H+/K+ ATPase enzyme (the proton pump) located in the gastric parietal cells. By blocking this enzyme, Pantoprazole effectively reduces the secretion of gastric acid into the stomach. The decreased acid production alleviates symptoms associated with acid reflux and protects the gastric mucosa from damage due to excessive acid.\n\nThe rapid onset of action provided by the intravenous route makes it especially useful for patients experiencing severe symptoms or those in critical care situations, where immediate acid suppression is necessary.\n\n \nDirections for Use:\n \n\nAdministration: PANTOSTRUM IV INJECTION should be administered by a healthcare professional.\nDosage: The typical adult dosage is 40 mg, administered once daily. For certain conditions, higher dosages or more frequent administration may be necessary, as determined by a physician.\nInfusion Method: The injection should be diluted appropriately and infused slowly over 2-15 minutes, as recommended in the prescribing information.\nNote: Always follow the healthcare provider’s instructions regarding dosage and duration of therapy.\n\n \nSide Effects:\n \n\nWhile PANTOSTRUM IV INJECTION is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nHeadache: A frequent side effect, which may resolve on its own.\nDiarrhea: Some patients may experience gastrointestinal disturbances.\nNausea/Vomiting: Mild nausea or vomiting may occur in some individuals.\nDizziness: A sensation of light-headedness can occur but is usually transient.\nInjection Site Reactions: Pain or irritation at the injection site may happen but is generally mild.\nSerious Side Effects: Although rare, serious side effects may include severe allergic reactions, liver dysfunction, or kidney problems. Seek immediate medical attention if any severe symptoms occur.", "price": 56.5, "discountamount": 16.95, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "other PPIs", "Regular use", "Mild nausea", "rapid onset", "acid reflux", "quick relief", "Rapid Relief", "2-15 minutes", "Key Benefits", "Most patients", "peptic ulcers", "Short-Term Use", "higher dosages", "excessive acid", "gastric mucosa", "kidney problems", "Infusion Method", "severe symptoms", "acid production", "acute conditions", "clinical setting", "longer durations", "oral medications", "acute situations", "liver dysfunction", "intravenous route", "potent medication", "chronic conditions", "Recurrent Symptoms", "oral administration", "healthcare provider", "H+/K+ ATPase enzyme", "Common side effects", "typical adult dosage", "frequent side effect", "acid-related symptoms", "short-term management", "injectable formulation", "acid-related disorders", "gastric acid secretion", "gastric parietal cells", "prescribing information", "healthcare professional", "intravenous formulation", "frequent administration", "PANTOSTRUM IV INJECTION", "Injection Site Reactions", "critical care situations", "favorable safety profile", "severe allergic reactions", "Zollinger-Ellison syndrome", "immediate acid suppression", "rare, serious side effects", "immediate medical attention", "gastrointestinal disturbances", "powerful proton pump inhibitor", "gastroesophageal reflux disease", "immediate therapeutic intervention" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1993, "imageuri": "https://productimages.withfloats.com/actual/67122b10ce3b6899c42f8e60.png", "tileimageuri": "https://productimages.withfloats.com/tile/67122b10ce3b6899c42f8e60.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-10-18T09:31:56.085Z", "updatedon": "2024-10-18T09:31:56.085Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pantoprazole-40-mg-/1993", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANTOSTRUM IV INJECTION ", "category": "GASTROLOGYRANGE", "tags": [ "pantop injection i.v. or im", "Pantoprazole injection uses", "Pantoprazole IV infusion guidelines", "Pantoprazole injection 40 mg uses", "Pan 40 Injection im or IV", "Pantoprazole injection uses", "Pantop इंजेक्शन in Hindi", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66617ed97de2b5203089cd4b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MENEROPEN 500 IV", "description": "MENEROPEN 500 IV\nMeropenem (500mg)\nMeropenem is an intravenous antibiotic medication used to treat severe bacterial infections. Each vial of Meneropen 500 IV contains 500mg of Meropenem, a potent broad-spectrum antibiotic effective against a wide range of bacteria. It belongs to the carbapenem class of antibiotics, known for their effectiveness against Gram-positive and Gram-negative bacteria.\n\nMeneropen 500 IV is commonly prescribed for infections such as pneumonia, urinary tract infections, intra-abdominal infections, and bacterial meningitis. It works by inhibiting the formation of bacterial cell walls, leading to bacterial cell death.\n\nDosage and administration of Meneropen 500 IV are typically determined by the severity of the infection, patient's age, and medical condition. It is administered intravenously by a healthcare professional in a hospital or clinical setting.\n\nCommon side effects of Meropenem may include nausea, diarrhea, headache, rash, and injection site reactions. Serious side effects such as allergic reactions or severe gastrointestinal disturbances are rare but possible.\n\nIt's important to complete the full course of Meneropen 500 IV as prescribed by your doctor, even if symptoms improve before the course is finished. Skipping doses or stopping early can lead to antibiotic resistance and treatment failure.\n\nMeneropen 500 IV is a prescription medication and should only be used under the guidance of a healthcare professional. Always inform your doctor about any other medications or health conditions you have before starting Meropenem therapy.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n\nhttps://www.sterisonline.com/product/meneropen-500-iv-133908\n\n\n\n\n\n\n\n", "price": 529.0, "discountamount": 159.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "vial", "rash", "Email", "doses", "500mg", "Dosage", "doctor", "nausea", "patient", "severity", "WhatsApp", "diarrhea", "headache", "symptoms", "guidance", "hospital", "pneumonia", "formation", "wide range", "full course", "antibiotics", "sterispharma", "sterisonline", "Gram-positive", "effectiveness", "administration", "carbapenem class", "Meneropen 500 IV", "clinical setting", "Meropenem therapy", "health conditions", "other medications", "treatment failure", "medical condition", "allergic reactions", "Common side effects", "bacterial meningitis", "bacterial cell death", "bacterial cell walls", "Serious side effects", "antibiotic resistance", "Gram-negative bacteria", "prescription medication", "healthcare professional", "urinary tract infections", "injection site reactions", "intra-abdominal infections", "severe bacterial infections", "potent broad-spectrum antibiotic", "intravenous antibiotic medication", "severe gastrointestinal disturbances" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1437, "imageuri": "https://productimages.withfloats.com/actual/66617edb8e77bb2c715688fb.png", "tileimageuri": "https://productimages.withfloats.com/tile/66617edb8e77bb2c715688fb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:18:17.237Z", "updatedon": "2024-06-29T09:19:22.888Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/meneropen-500-iv/1437", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MENEROPEN 500 IV", "category": "GENERAL RANGE", "tags": [ "MENEROPEN 500 IV", "Meropenem (500mg)", "Meropenem 500 mg price", "Meropenem 500 mg Injection price", "Tab Meropenem 500 mg uses", "Tab meropenem 500 mg dose", "Meropenem 500 mg IV" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "66617e16870e7b20c49e51f7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MENEROPEN 1 GM IV ", "description": "MENEROPEN 1 GM IV \nMeropenem (1000mg)\nMeneropen 1 gm IV is a potent antibiotic containing Meropenem in a dosage of 1000mg. It is primarily used to treat severe bacterial infections caused by sensitive organisms. This medication works by inhibiting the growth of bacteria, thus helping the body fight off infections effectively.\n\nMeropenem belongs to the class of antibiotics known as carbapenems, which are broad-spectrum antibiotics effective against a wide range of bacteria. It is commonly used to treat infections such as pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and bacterial meningitis.\n\nThis medication is administered intravenously, usually in a hospital setting under the supervision of a healthcare professional. The dosage and duration of treatment may vary depending on the severity of the infection, the patient's age, and other medical conditions.\n\nLike all medications, Meneropen 1 gm IV may cause side effects such as nausea, diarrhea, headache, dizziness, or allergic reactions in some individuals. It is important to inform your healthcare provider about any allergies or medical conditions you may have before starting this medication.\n\nOverall, Meneropen 1 gm IV is a valuable antibiotic used to treat serious bacterial infections and should be used as directed by a healthcare professional.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n\nhttps://www.sterisonline.com/product/meneropen-1-gm-iv-133907\n\n\n\n\n\n\n", "price": 1099.0, "discountamount": 330.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "skin", "body", "Email", "class", "growth", "nausea", "1000mg", "dosage", "patient", "product", "headache", "severity", "diarrhea", "duration", "WhatsApp", "allergies", "Meropenem", "dizziness", "pneumonia", "treatment", "wide range", "medication", "information", "individuals", "carbapenems", "supervision", "sterisonline", "side effects", "sterispharma", "hospital setting", "potent antibiotic", "MENEROPEN 1 GM IV", "allergic reactions", "sensitive organisms", "valuable antibiotic", "healthcare provider", "bacterial meningitis", "soft tissue infections", "healthcare professional", "other medical conditions", "urinary tract infections", "intra-abdominal infections", "broad-spectrum antibiotics", "severe bacterial infections", "serious bacterial infections" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1436, "imageuri": "https://productimages.withfloats.com/actual/66617e1853245b8b6b4a4a53.png", "tileimageuri": "https://productimages.withfloats.com/tile/66617e1853245b8b6b4a4a53.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:15:02.305Z", "updatedon": "2024-06-29T09:19:33.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/meneropen-1-gm-iv-/1436", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MENEROPEN 1 GM IV ", "category": "GENERAL RANGE", "tags": [ "MENEROPEN 1 GM IV", "Meropenem (1000mg)", "Meropenem 1000 mg Injection price", "मेरोपेनेम 1gm", "Meropenem 1,000 mg side effects", "Meropenem tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6916c002d152b8cabef859ea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Miltefosine Capsules", "description": "Miltefosine Capsules are an important oral medication widely recognized for their effectiveness in treating Visceral Leishmaniasis (Kala-azar), Cutaneous Leishmaniasis, and certain protozoal infections. As the first and only oral drug approved for the treatment of Leishmaniasis, Miltefosine has significantly transformed patient care by offering a convenient and reliable alternative to painful injectable therapies. The medication belongs to the class of alkylphosphocholine drugs and is known for its potent antiparasitic and cytotoxic actions.\n\nMiltefosine Capsules are typically prescribed by healthcare professionals when a confirmed diagnosis of Leishmaniasis has been made, or when the patient is not responding adequately to other modes of therapy. Its high absorption rate, ease of administration, and consistent therapeutic activity make it a cornerstone in parasitic infection management across endemic regions.\n\nWhat Are Miltefosine Capsules?\n\nMiltefosine is an oral antiparasitic medication designed to eliminate Leishmania parasites by disrupting their cell membranes and metabolic functions. It was originally studied for anticancer activities but later found to be highly effective against various Leishmania species. Unlike conventional treatment options that require hospitalization and injections, Miltefosine offers a non-invasive, at-home oral therapy option, improving both patient comfort and compliance.\n\nMiltefosine Capsules are generally marketed in different strengths such as 50 mg. The duration of treatment usually ranges between 28–30 days depending on the medical condition and severity.\n\nUses of Miltefosine Capsules\n\nMiltefosine Capsules are primarily prescribed for:\n\n1. Visceral Leishmaniasis (Kala-azar)\n\nThis is a severe, life-threatening parasitic disease affecting internal organs such as the spleen, liver, and bone marrow. Miltefosine is considered one of the most effective oral treatment options for Kala-azar and is widely used in India and other tropical regions where the disease is endemic.\n\n2. Cutaneous Leishmaniasis\n\nIt causes skin lesions, ulcers, and disfiguring scars. Miltefosine works by targeting the parasite in skin tissues, promoting faster healing and reducing complications.\n\n3. Mucocutaneous Leishmaniasis\n\nThough less common, this form affects mucous membranes of the nose, mouth, and throat. Miltefosine plays a major role in preventing progressive tissue destruction.\n\n4. Off-Label Uses\n\nIn some cases, doctors may prescribe Miltefosine for:\n\nCertain protozoal infections\n\nAmoebic keratitis (rare condition affecting the eye)\n\nParasitic infections resistant to other treatments\n\nHowever, these uses should only be followed under strict medical supervision.\n\nHow Miltefosine Works\n\nMiltefosine acts directly on parasitic cells by:\n\nDisrupting cell membrane integrity\n\nInterfering with phospholipid metabolism\n\nTriggering apoptosis-like cell death in parasites\n\nWeakening parasite reproduction and survival\n\nThis multi-target mechanism makes Miltefosine one of the most powerful oral antiparasitic medications available today.\n\nKey Benefits of Miltefosine Capsules\n1. Highly Effective Oral Treatment\n\nUnlike older treatments requiring multiple injections, Miltefosine provides a simple oral dosage, eliminating the need for hospitalization or painful procedures.\n\n2. Excellent Patient Compliance\n\nThe convenience of taking capsules at home significantly improves adherence to treatment, especially in rural or resource-limited areas.\n\n3. Strong Activity Against Leishmania Species\n\nMiltefosine’s broad-spectrum antiparasitic properties make it effective against several strains of Leishmania responsible for different clinical presentations of the disease.\n\n4. Lower Risk of Severe Treatment Complications\n\nCompared to traditional injectable therapies like antimonials, Miltefosine has a better safety profile when used under medical supervision.\n\n5. Reduces Disease Transmission\n\nBy effectively eliminating parasites from the body, Miltefosine helps reduce the overall disease burden in endemic communities.\n\n6. Faster Healing of Skin Lesions\n\nPatients with Cutaneous Leishmaniasis experience faster recovery, reduced lesion size, and minimal scarring when treatment is taken on time.\n\n7. Well-Studied and Recommended\n\nMiltefosine is recommended by WHO and national health authorities in many countries as a frontline treatment for Kala-azar.\n\nPossible Side Effects of Miltefosine Capsules\n\nWhile generally well tolerated, Miltefosine may cause certain side effects. Most of these are mild to moderate and subside as the body adapts to the medication.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nAbdominal discomfort\n\nLoss of appetite\n\nTemporary weakness or fatigue\n\nModerate Side Effects\n\nElevated liver enzymes\n\nMild kidney function changes\n\nSkin reactions such as redness or itching\n\nSevere, But Less Common Side Effects\n\nNephrotoxicity (kidney-related issues)\n\nHepatotoxicity (liver-related issues)\n\nSevere gastrointestinal upset\n\nVision-related disturbances in very rare cases\n\nImportant Warning for Women\n\nMiltefosine is NOT recommended during pregnancy as it can cause fetal harm. Women of childbearing age must use reliable contraception during treatment and for at least 3 months after therapy.\n\nPrecautions\n\nPatients with the following conditions should use Miltefosine cautiously:\n\nLiver or kidney disease\n\nPregnancy or breastfeeding\n\nSevere dehydration\n\nUncontrolled vomiting or diarrhea\n\nAlways follow the dosage exactly as prescribed by a healthcare professional.\n\nConclusion\n\nMiltefosine Capsules have revolutionized the treatment of various forms of Leishmaniasis by offering a powerful, effective, and convenient oral therapy option. Their ability to target parasitic infections through multiple mechanisms makes them a trusted solution in endemic regions. Whether used for Visceral, Cutaneous, or Mucocutaneous Leishmaniasis, Miltefosine provides significant therapeutic benefits, faster recovery, and improved patient compliance.", "price": 1350.0, "discountamount": 405.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2205, "imageuri": "https://productimages.withfloats.com/actual/6916c0042444cd45b3f0f253.png", "tileimageuri": "https://productimages.withfloats.com/tile/6916c0042444cd45b3f0f253.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-14T05:37:06.048Z", "updatedon": "2025-11-14T05:37:06.048Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/miltefosine-capsules/2205", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MILTEFOSE 50", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6912fc8c470ec71b0ac87646", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mometasone Furoate and Formoterol Fumarate Inhaler", "description": "Mometasone Furoate and Formoterol Fumarate Inhaler is a combination respiratory medication formulated to provide effective and long-lasting control of asthma and chronic obstructive pulmonary disease (COPD). It combines two powerful active ingredients — Mometasone Furoate, a corticosteroid (anti-inflammatory), and Formoterol Fumarate, a long-acting bronchodilator (LABA). Together, these components help patients breathe easier by reducing airway inflammation and relaxing the muscles of the airways.\n\nThis dual-action inhaler is designed for maintenance therapy rather than immediate relief of acute symptoms. By targeting both inflammation and bronchial constriction, it provides a comprehensive approach to long-term respiratory management. Each inhalation delivers a precise dose to ensure consistent therapeutic results and improved lung function.\n\nMometasone Furoate and Formoterol Fumarate Inhaler is ideal for individuals who experience persistent asthma symptoms or airflow obstruction due to COPD, despite using single-ingredient inhalers.\n\nUses and Therapeutic Indications\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler is prescribed for the following respiratory conditions:\n\nAsthma (Bronchial Asthma):\n\nUsed for the long-term control and prevention of symptoms such as wheezing, breathlessness, and chest tightness.\n\nHelps reduce inflammation and airway hyperreactivity to prevent asthma attacks.\n\nChronic Obstructive Pulmonary Disease (COPD):\n\nHelps manage chronic bronchitis and emphysema by improving airflow and reducing airway inflammation.\n\nMaintenance Therapy:\n\nProvides ongoing treatment for patients whose symptoms are not adequately controlled by inhaled corticosteroids or bronchodilators alone.\n\nThis inhaler is not meant for emergency relief during sudden asthma attacks but rather as a daily maintenance therapy to control symptoms and prevent exacerbations.\n\nKey Benefits\n\nDual Mechanism of Action:\nCombines the anti-inflammatory power of Mometasone Furoate with the bronchodilating action of Formoterol Fumarate, offering complete respiratory control in one inhaler.\n\nReduces Airway Inflammation:\nMometasone Furoate suppresses the body’s inflammatory response, helping reduce swelling, mucus buildup, and irritation in the airways.\n\nLong-Lasting Bronchodilation:\nFormoterol provides fast and sustained relaxation of airway muscles, improving airflow and making breathing easier for up to 12 hours.\n\nImproves Lung Function:\nRegular use enhances pulmonary capacity, allowing patients to perform daily activities without breathing difficulty.\n\nFewer Asthma Exacerbations:\nReduces the frequency and severity of asthma attacks and flare-ups associated with COPD.\n\nConvenient Combination Therapy:\nProvides the benefits of two medications in a single device, improving compliance and simplifying treatment routines.\n\nBetter Symptom Control:\nProven to decrease wheezing, coughing, and nighttime symptoms, leading to better sleep and overall quality of life.\n\nRapid Onset of Action:\nFormoterol acts within minutes to ease breathing while Mometasone works continuously to maintain long-term inflammation control.\n\nPossible Side Effects\n\nWhile the Mometasone Furoate and Formoterol Fumarate Inhaler is well tolerated, some individuals may experience mild to moderate side effects, especially during the early phase of therapy. These include:\n\nThroat Irritation or Dryness\n\nHoarseness or Voice Changes\n\nHeadache or Dizziness\n\nCough or Upper Respiratory Tract Infections\n\nMuscle Cramps or Tremors\n\nPalpitations (Fast or Irregular Heartbeat)\n\nNausea or Mild Stomach Upset\n\nOral Thrush (Fungal Infection in the Mouth or Throat) – often preventable by rinsing the mouth with water after inhalation.\n\nPrecautions:\n\nThis inhaler is not a rescue medication; a short-acting bronchodilator should be kept on hand for sudden breathing attacks.\n\nRegular use is essential for best results — do not stop suddenly without consulting a doctor.\n\nPatients with heart conditions, hypertension, thyroid disorders, diabetes, or osteoporosis should use this medicine under medical supervision.\n\nAlways rinse the mouth after use to prevent fungal infections.\n\nConclusion\n\nThe Mometasone Furoate and Formoterol Fumarate Inhaler represents a modern, evidence-based approach to managing chronic respiratory conditions such as asthma and COPD. By combining a corticosteroid (to reduce airway inflammation) with a long-acting bronchodilator (to open the airways), it provides effective, dual-action relief that lasts throughout the day.\n\nRegular use of this inhaler helps improve breathing capacity, reduces symptom frequency, and enhances quality of life for individuals struggling with chronic lung diseases. It not only helps patients achieve better control over their respiratory symptoms but also reduces the need for emergency interventions and hospitalizations.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2199, "imageuri": "https://productimages.withfloats.com/actual/6912fc8e6447ec42b9808956.png", "tileimageuri": "https://productimages.withfloats.com/tile/6912fc8e6447ec42b9808956.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-11T09:06:20.511Z", "updatedon": "2025-11-11T09:06:20.511Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mometasone-furoate-and-formoterol-fumarate-inhaler/2199", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MONTASENSE F INH", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "690b41bfb84ade1a1a5cf07f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tiotropium Bromide and Formoterol Fumarate Inhaler", "description": "Tiotropium Bromide and Formoterol Fumarate Inhaler is a combination medication designed to provide long-term relief for patients suffering from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and asthma. This inhaler combines the bronchodilator properties of tiotropium bromide with the fast-acting benefits of formoterol fumarate, ensuring both immediate and sustained relief from breathing difficulties. By improving airflow in the lungs, this inhaler significantly enhances the quality of life for individuals with obstructive airway diseases.\n\nComposition and Mechanism of Action\nThe inhaler contains two active ingredients:\n\nTiotropium Bromide – a long-acting anticholinergic agent that relaxes the muscles around the airways, preventing bronchospasm and helping to keep the airways open for an extended period.\n\nFormoterol Fumarate – a long-acting beta-2 adrenergic agonist (LABA) that quickly relaxes airway muscles, providing fast relief from shortness of breath and wheezing.\n\nTogether, these agents work synergistically. Tiotropium ensures long-term bronchodilation, while formoterol provides rapid symptom relief, making this inhaler ideal for patients who require both immediate and sustained respiratory support.\n\nUses\nThe Tiotropium Bromide and Formoterol Fumarate Inhaler is primarily used to:\n\nManage Chronic Obstructive Pulmonary Disease (COPD) – Helps reduce the frequency and severity of COPD exacerbations, improving breathing efficiency.\n\nControl Asthma Symptoms – Offers better control of persistent asthma symptoms, particularly in patients who do not respond adequately to standard inhalers.\n\nPrevent Exercise-Induced Bronchospasm – Can be used as part of a preventive regimen for patients prone to exercise-triggered breathing difficulties.\n\nEnhance Overall Lung Function – Improves airflow and oxygen exchange, contributing to better overall respiratory health.\n\nDosage and Administration\nProper usage of the inhaler is critical for maximum effectiveness. The dosage may vary based on your condition and doctor's recommendation. General guidelines include:\n\nTypically, one inhalation twice daily (morning and evening).\n\nShake the inhaler well before each use.\n\nExhale fully, place the mouthpiece in your mouth, and inhale deeply while pressing the inhaler to release the medication.\n\nHold your breath for 10 seconds after inhalation to ensure the medication reaches deep into the lungs.\n\nRinse your mouth with water after use to reduce the risk of oral infections or irritation.\n\nPatients should strictly follow their doctor’s instructions regarding dosage, frequency, and technique, as incorrect use may reduce the medication’s effectiveness.\n\nKey Benefits\n\nDual Action for Immediate and Long-Term Relief – Combines a fast-acting bronchodilator with a long-acting maintenance agent.\n\nReduces Exacerbations – Regular use can significantly lower the risk of flare-ups and hospital visits for COPD or severe asthma patients.\n\nImproves Lung Function – Enhances airflow and oxygen intake, leading to reduced shortness of breath and wheezing.\n\nConvenient Usage – A single inhaler provides both maintenance and symptom relief, reducing the need for multiple medications.\n\nEnhanced Quality of Life – Patients often experience better sleep, increased physical activity tolerance, and improved daily functioning.\n\nSide Effects\nWhile Tiotropium Bromide and Formoterol Fumarate Inhaler is generally well-tolerated, some patients may experience side effects. Common side effects include:\n\nDry mouth or throat irritation\n\nCough or hoarseness\n\nHeadache or dizziness\n\nTremors or mild palpitations\n\nSerious but rare side effects may include:\n\nSevere allergic reactions (rash, swelling, difficulty breathing)\n\nIrregular heartbeat or chest pain\n\nWorsening of respiratory symptoms\n\nPatients should immediately consult a healthcare professional if they experience severe or persistent side effects. Regular follow-up with a doctor is recommended to monitor lung function and adjust the dosage if necessary.\n\nPrecautions\n\nNot recommended for individuals with hypersensitivity to either tiotropium bromide or formoterol fumarate.\n\nShould be used cautiously in patients with cardiovascular diseases, kidney or liver problems, or thyroid disorders.\n\nAvoid sudden discontinuation without consulting your doctor, as this may worsen symptoms.\n\nAlways carry a rescue inhaler for emergency situations, as this inhaler is primarily for maintenance and not for immediate acute attacks.\n\nPrice\nThe price of Tiotropium Bromide and Formoterol Fumarate Inhaler may vary depending on the brand, pack size, and pharmacy. It is advisable to compare prices and check with local pharmacies for the most cost-effective options. Many insurance plans may cover this inhaler under prescription respiratory medications.\n\nConclusion\nTiotropium Bromide and Formoterol Fumarate Inhaler is a highly effective combination treatment for patients suffering from COPD and asthma. By providing both rapid symptom relief and long-term airway maintenance, it helps patients breathe more easily, reduces the frequency of exacerbations, and improves overall quality of life. Proper usage, adherence to prescribed dosage, and monitoring for side effects are essential for achieving the best results. For anyone managing chronic respiratory conditions, this inhaler represents a reliable and convenient treatment option under medical guidance.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2196, "imageuri": "https://productimages.withfloats.com/actual/690b41c1d25e5639c9089541.png", "tileimageuri": "https://productimages.withfloats.com/tile/690b41c1d25e5639c9089541.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-05T12:23:27.485Z", "updatedon": "2025-11-05T12:23:27.485Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tiotropium-bromide-and-formoterol-fumarate-inhaler/2196", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TIOTROPIN F", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6908575f0c31b1295dc50d7e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ursodeoxycholic Acid 600 mg", "description": "Ursodeoxycholic Acid 600 mg is a clinically trusted and widely prescribed medication used in the management of liver and gallbladder disorders. Belonging to the class of bile acid derivatives, it plays a vital role in improving liver function and dissolving certain types of gallstones without surgery. This medicine is commonly prescribed to patients suffering from cholestatic liver diseases, such as primary biliary cholangitis (PBC), non-alcoholic fatty liver disease (NAFLD), and bile reflux gastritis.\n\nIn the Indian healthcare setting, Ursodeoxycholic Acid (also known as UDCA) has become a cornerstone therapy for liver protection. It is known not only for its effectiveness in improving bile flow but also for its anti-inflammatory, immunomodulatory, and cytoprotective properties. The 600 mg strength formulation provides an optimal dose for adult patients, ensuring consistent bile regulation and liver cell protection.\n\nProduced under stringent quality control by leading pharmaceutical companies like Steris Healthcare Pvt. Ltd., Ursodeoxycholic Acid 600 mg ensures purity, efficacy, and patient safety. This makes it a dependable choice for clinicians and patients managing chronic liver diseases in India.\n\nWhat is Ursodeoxycholic Acid?\n\nUrsodeoxycholic Acid (UDCA) is a naturally occurring bile acid that is present in small amounts in the human body. It is synthesized and used as a medication to treat liver and gallbladder conditions by altering bile composition and reducing the production of toxic bile acids.\n\nChemically, Ursodeoxycholic Acid is a hydrophilic bile acid, meaning it has a high affinity for water and helps replace harmful hydrophobic bile acids that can damage liver cells. It is known for its ability to protect hepatocytes (liver cells) from injury, enhance bile secretion, and dissolve cholesterol-based gallstones.\n\nBy reducing bile cholesterol saturation and promoting bile flow, UDCA helps maintain liver function, especially in conditions where bile flow is obstructed or impaired.\n\nMechanism of Action\n\nThe therapeutic action of Ursodeoxycholic Acid is multifaceted:\n\nBile Flow Regulation:\nUDCA improves bile secretion and reduces bile stasis (retention). This helps in clearing toxic bile acids from the liver, thereby preventing inflammation and fibrosis.\n\nCytoprotective Effect:\nIt stabilizes the hepatocyte (liver cell) membrane and reduces damage caused by bile acid-induced oxidative stress.\n\nImmunomodulatory Action:\nUrsodeoxycholic Acid reduces autoimmune destruction of bile ducts in diseases like primary biliary cholangitis by modulating immune response.\n\nCholesterol Reduction:\nUDCA decreases the cholesterol content of bile and suppresses hepatic cholesterol synthesis, leading to the gradual dissolution of cholesterol gallstones.\n\nAntifibrotic and Anti-inflammatory Role:\nBy reducing inflammation and fibrosis markers, UDCA helps slow the progression of chronic liver diseases.\n\nTherapeutic Uses of Ursodeoxycholic Acid 600 mg\n\nUrsodeoxycholic Acid 600 mg tablets are prescribed for a wide range of liver and gallbladder-related conditions. Below are the major medical indications:\n\n1. Primary Biliary Cholangitis (PBC):\n\nOne of the most common uses of UDCA is in treating primary biliary cholangitis, an autoimmune condition that causes slow, progressive destruction of bile ducts within the liver. Ursodeoxycholic Acid helps improve bile flow, reduce bilirubin levels, and delay the need for liver transplantation in many patients.\n\n2. Cholestatic Liver Diseases:\n\nIt is used to treat cholestatic conditions where bile secretion is impaired, such as:\n\nIntrahepatic cholestasis during pregnancy\n\nDrug-induced cholestasis\n\nChronic cholestatic hepatitis\n\nPost-surgical biliary obstruction\n\n3. Gallstone Dissolution (Cholesterol Gallstones):\n\nUrsodeoxycholic Acid 600 mg is effective in dissolving small, non-calcified cholesterol gallstones in patients who cannot undergo surgery. It works by reducing cholesterol saturation in bile, gradually breaking down gallstones over several months.\n\n4. Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH):\n\nIn patients with fatty liver or metabolic liver disorders, UDCA helps improve liver enzyme levels and reduces oxidative stress, supporting better liver health.\n\n5. Bile Reflux Gastritis:\n\nUDCA is used to relieve symptoms caused by bile reflux into the stomach, such as epigastric pain, bloating, and nausea.\n\n6. Cystic Fibrosis-Related Liver Disease:\n\nIt can be used to improve bile flow and prevent hepatic complications in patients with cystic fibrosis.\n\n7. Post Liver Transplantation:\n\nUDCA is sometimes used as supportive therapy to prevent graft-related cholestasis and maintain optimal liver function after transplantation.\n\nKey Benefits of Ursodeoxycholic Acid 600 mg\n1. Promotes Healthy Liver Function\n\nUrsodeoxycholic Acid supports liver detoxification and enhances bile secretion, reducing bile stasis and protecting hepatocytes from toxic damage.\n\n2. Dissolves Cholesterol Gallstones Naturally\n\nUnlike surgical interventions, UDCA provides a non-invasive way to dissolve cholesterol gallstones, especially in patients unfit for surgery.\n\n3. Protects Liver Cells from Damage\n\nUDCA stabilizes the hepatocyte membrane and reduces cell injury caused by bile acids, alcohol, or medications.\n\n4. Reduces Inflammation and Fibrosis\n\nIts anti-inflammatory and antifibrotic properties help slow down the progression of chronic liver diseases.\n\n5. Regulates Cholesterol Levels\n\nUrsodeoxycholic Acid lowers bile cholesterol concentration, which helps maintain a balanced lipid profile and prevents gallstone formation.\n\n6. Supports Recovery in Liver Disorders\n\nIn patients with hepatitis, fatty liver, or cirrhosis, UDCA helps improve liver enzyme levels (ALT, AST, ALP), signaling better liver recovery.\n\n7. Improves Digestive Function\n\nBy improving bile flow, UDCA enhances fat digestion and reduces symptoms like bloating, nausea, and postprandial discomfort.\n\n8. Safe for Long-Term Use\n\nWhen prescribed under medical supervision, Ursodeoxycholic Acid 600 mg is well-tolerated and safe for prolonged treatment of chronic liver diseases.\n\nDosage and Administration\n\nRecommended Dose: The typical adult dose of Ursodeoxycholic Acid ranges between 8–12 mg per kilogram of body weight per day, which equals about 600 mg once or twice daily depending on the patient’s condition.\n\nFormulation: Tablet form (Ursodeoxycholic Acid 600 mg)\n\nMode of Administration: Oral\n\nTiming: It should be taken with meals to enhance absorption and reduce gastrointestinal side effects.\n\nTreatment Duration:\n\nFor gallstone dissolution, therapy may last for 6 months to 2 years.\n\nFor chronic liver conditions, treatment may be long-term or lifelong under physician guidance.\n\nImportant Note:\nThe dosage should be individualized based on body weight, liver function, and medical condition. Patients must not self-medicate and should take the medicine only as prescribed by a healthcare professional.\n\nPrecautions and Warnings\n\nBefore using Ursodeoxycholic Acid 600 mg, patients should consider the following precautions:\n\nMedical Supervision Required:\nAlways use this medicine under the guidance of a doctor, particularly if you have a history of severe liver or gallbladder disease.\n\nAvoid in Certain Gallstones:\nUDCA is not effective for calcified or pigment gallstones.\n\nPregnancy and Breastfeeding:\nWhile UDCA is considered relatively safe during pregnancy, it should only be used when prescribed by a physician. Minimal amounts may pass into breast milk.\n\nMonitor Liver Function:\nRegular liver function tests (LFTs) are advised during treatment to monitor therapeutic response and liver health.\n\nDrug Interactions:\nAvoid concurrent use with:\n\nAluminum-based antacids (reduce UDCA absorption)\n\nCholestyramine or Colestipol (interfere with bile acid absorption)\n\nCiclosporin or Estrogens (may alter bile composition)\n\nAlcohol Consumption:\nAlcohol can strain the liver and reduce the effectiveness of UDCA therapy. Patients should limit or avoid alcohol during treatment.\n\nGastrointestinal Disorders:\nUse with caution in patients with peptic ulcer, severe diarrhea, or gastrointestinal inflammation.\n\nPossible Side Effects of Ursodeoxycholic Acid 600 mg\n\nUrsodeoxycholic Acid is generally well-tolerated, but some patients may experience mild to moderate side effects. These are typically temporary and improve as the body adjusts to the medication.\n\nCommon Side Effects:\n\nDiarrhea or loose stools\n\nNausea and vomiting\n\nAbdominal discomfort\n\nIndigestion or bloating\n\nHeadache\n\nDizziness\n\nLess Common Side Effects:\n\nRash or itching (urticaria)\n\nIncreased liver enzymes (temporary)\n\nBack pain or joint pain\n\nCough or upper respiratory infection symptoms\n\nRare but Serious Side Effects:\n\nSevere right upper abdominal pain (may indicate gallstone complications)\n\nJaundice or dark urine (signs of liver stress)\n\nPersistent diarrhea or dehydration\n\nAllergic reaction (swelling, rash, or shortness of breath)\n\nNote:\nIf any of these side effects persist or worsen, it is important to inform your doctor immediately. Never stop or alter the dosage without consulting your healthcare provider.\n\nSafety in Special Populations\nPregnancy:\n\nUDCA is sometimes used to treat intrahepatic cholestasis of pregnancy (ICP) under strict medical supervision. While generally safe, dosage adjustment and monitoring are essential.\n\nLactation:\n\nIt is considered safe in breastfeeding mothers as minimal quantities are excreted into breast milk.\n\nElderly Patients:\n\nNo specific dosage adjustment is needed, but liver function should be monitored regularly.\n\nChildren:\n\nUrsodeoxycholic Acid can be prescribed in pediatric doses for liver-related disorders, particularly biliary atresia, under pediatric supervision.\n\nStorage and Handling\n\nStore in a cool, dry place below 25°C.\n\nProtect from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use after the expiry date printed on the pack.\n\nClinical Efficacy and Research Insights\n\nClinical studies across India and globally have confirmed the efficacy of Ursodeoxycholic Acid in managing chronic liver and biliary diseases. Long-term use of UDCA has shown:\n\nImprovement in liver enzyme profiles (AST, ALT, ALP).\n\nReduction in bilirubin levels in cholestatic conditions.\n\nDelay in disease progression in primary biliary cholangitis.\n\nReduction in gallstone size and formation rate with consistent therapy.\n\nBetter quality of life scores among patients with chronic liver conditions.\n\nIts established safety profile and biochemical benefits make Ursodeoxycholic Acid a cornerstone therapy in hepatology.\n\nLifestyle and Dietary Recommendations During Treatment\n\nTo enhance the effectiveness of UDCA therapy and support liver health, patients are advised to:\n\nMaintain a Balanced Diet:\nInclude fresh fruits, vegetables, whole grains, and lean proteins. Avoid fatty, fried, and processed foods.\n\nStay Hydrated:\nDrink sufficient water to aid digestion and toxin elimination.\n\nLimit Alcohol and Caffeine:\nBoth can strain liver metabolism and interfere with medication effectiveness.\n\nExercise Regularly:\nModerate physical activity helps improve liver function and reduce fat accumulation.\n\nAvoid Self-Medication:\nConsult your doctor before using any over-the-counter supplements or herbal products.\n\nFrequently Asked Questions (FAQs)\n\nQ1. How long should Ursodeoxycholic Acid 600 mg be taken?\nThe duration depends on your condition. For gallstone dissolution, treatment may last 6–24 months. For chronic liver diseases, long-term therapy may be recommended.\n\nQ2. Can Ursodeoxycholic Acid cure liver disease completely?\nWhile it does not cure liver disease, UDCA can slow its progression, protect liver cells, and improve biochemical and clinical outcomes.\n\nQ3. Can I take Ursodeoxycholic Acid on an empty stomach?\nIt is best taken with food to enhance absorption and minimize stomach upset.\n\nQ4. Does it interact with other medications?\nYes. Antacids, cholesterol-binding resins, and estrogens may interfere with UDCA absorption or activity. Always inform your doctor about all medications you’re taking.\n\nQ5. How long does it take to see results?\nLiver function improvement can often be observed within a few weeks, but gallstone dissolution may take several months of consistent use.\n\nConclusion\n\nUrsodeoxycholic Acid 600 mg is a trusted and clinically validated therapy for various liver and gallbladder conditions. Its unique ability to enhance bile flow, protect liver cells, and dissolve cholesterol gallstones makes it an indispensable part of hepatology treatment protocols.", "price": 1385.0, "discountamount": 415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2195, "imageuri": "https://productimages.withfloats.com/actual/69099314f017379146dfffdc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69099314f017379146dfffdc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-03T07:18:55.866Z", "updatedon": "2025-11-04T05:47:50.392Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ursodeoxycholic-acid-600-mg/2195", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris healthcare Pvt Ltd", "category": "GASTROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6905fe704704b5ad3ff33652", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Salmeterol and Fluticasone Propionate Inhalation IP ", "description": "Salmeterol and Fluticasone Propionate Inhalation IP is a combination medication widely used for the management and long-term treatment of asthma and chronic obstructive pulmonary disease (COPD). This dual-acting inhalation therapy combines two powerful active ingredients — Salmeterol, a long-acting bronchodilator, and Fluticasone Propionate, a corticosteroid. Together, they work synergistically to ease breathing difficulties, control inflammation, and prevent respiratory flare-ups.\n\nIn India, respiratory diseases such as asthma and COPD affect millions of people, especially due to pollution, smoking, and changing environmental conditions. For these individuals, Salmeterol and Fluticasone Propionate Inhalation IP serves as a cornerstone therapy that offers reliable control of symptoms and improves overall lung function.\n\nComposition and Mechanism of Action\n\nThis inhalation medication contains:\n\nSalmeterol (50 mcg) – a long-acting β₂-adrenergic receptor agonist (LABA) that relaxes airway muscles, allowing air to flow more freely into the lungs.\n\nFluticasone Propionate (250 mcg or 500 mcg) – a potent corticosteroid that helps reduce inflammation, swelling, and mucus production in the airways.\n\nWhen inhaled, Salmeterol provides prolonged bronchodilation, maintaining open airways for up to 12 hours, while Fluticasone acts directly on lung tissues to minimize inflammatory responses. This dual mechanism ensures both immediate relief and long-term control of respiratory symptoms.\n\nUses of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Asthma\n\nThis combination is one of the most prescribed maintenance therapies for asthma management. It helps reduce the frequency and severity of asthma attacks, improves breathing capacity, and enables patients to lead a more active lifestyle.\n\n2. Chronic Obstructive Pulmonary Disease (COPD)\n\nIt is also indicated for COPD, including chronic bronchitis and emphysema. In these conditions, it helps relieve breathlessness, persistent cough, and wheezing, thereby improving lung efficiency and quality of life.\n\n3. Prevention of Asthma Exacerbations\n\nRegular use of this inhalation helps prevent sudden asthma flare-ups triggered by allergens, cold weather, or exercise.\n\n4. Improvement of Lung Function\n\nBy consistently controlling inflammation and relaxing airway muscles, the medication enhances FEV₁ (Forced Expiratory Volume), a measure of how efficiently a patient can exhale.\n\nKey Benefits of Salmeterol and Fluticasone Propionate Inhalation IP\n1. Dual Therapeutic Action\n\nThe combination of a bronchodilator (Salmeterol) and an anti-inflammatory (Fluticasone) provides comprehensive control over both the causes and symptoms of respiratory conditions.\n\n2. Long-Lasting Relief\n\nWith its long-acting formulation, patients experience up to 12 hours of relief, reducing the need for frequent dosing and ensuring steady symptom control throughout the day or night.\n\n3. Prevention of Asthma and COPD Attacks\n\nRegular use helps minimize acute exacerbations, reducing hospital visits, emergency interventions, and dependency on quick-relief inhalers.\n\n4. Improved Breathing Comfort\n\nBy opening up constricted airways and controlling inflammation, it allows for easier breathing, better oxygen exchange, and improved stamina in daily activities.\n\n5. Enhanced Quality of Life\n\nPatients on regular inhalation therapy report fewer night-time symptoms, improved sleep, and better physical endurance, allowing them to enjoy an active, productive life.\n\n6. Targeted Lung Delivery\n\nAs an inhalation-based therapy, it directly delivers medication to the lungs where it’s most needed, minimizing systemic exposure and potential side effects.\n\nHow to Use\n\nShake the inhaler well before use to ensure even distribution of medicine.\n\nExhale fully and then inhale deeply through the mouthpiece while pressing down the canister to release one dose.\n\nHold your breath for a few seconds to allow the medicine to reach deep into the lungs.\n\nRinse your mouth after use to reduce the risk of fungal infections like oral thrush.\n\nPatients are advised to use the inhaler regularly at the same time each day for best results. It is not meant for sudden asthma attacks — a separate rescue inhaler should be kept for emergency relief.\n\nPossible Side Effects\n\nLike any medication, Salmeterol and Fluticasone Propionate Inhalation IP may cause mild to moderate side effects, though not everyone experiences them. Common side effects include:\n\n1. Oral and Throat Irritation\n\nDryness, irritation, or hoarseness of the throat may occur. Rinsing the mouth after use helps minimize this.\n\n2. Oral Thrush (Candidiasis)\n\nProlonged corticosteroid use can increase the risk of fungal infections in the mouth. Maintaining oral hygiene is essential.\n\n3. Headache or Dizziness\n\nSome users may experience mild headaches or lightheadedness, which typically subside over time.\n\n4. Muscle or Joint Pain\n\nOccasional mild muscle cramps or joint discomfort may occur, especially in long-term use.\n\n5. Palpitations or Tremors\n\nIn rare cases, Salmeterol may cause a slight increase in heart rate or mild tremors, particularly when the dose is higher than recommended.\n\n6. Cough or Respiratory Discomfort\n\nMild coughing or a temporary feeling of breath tightness may occur immediately after inhalation but usually passes quickly.\n\nIf any side effects persist or worsen, it is advisable to consult a healthcare professional immediately.\n\nPrecautions and Warnings\n\nNot for sudden asthma attacks — this inhaler should be used only for maintenance therapy.\n\nPregnant or breastfeeding women should use it only after medical advice.\n\nDo not exceed the prescribed dose as overuse may increase the risk of cardiovascular side effects.\n\nPatients with heart disease, hypertension, or diabetes should inform their doctor before starting treatment.\n\nAlways store the inhaler in a cool, dry place, away from direct sunlight and moisture.\n\nConclusion\n\nSalmeterol and Fluticasone Propionate Inhalation IP is a clinically proven, reliable treatment option for individuals suffering from chronic respiratory conditions like asthma and COPD. By combining the bronchodilatory power of Salmeterol with the anti-inflammatory efficacy of Fluticasone Propionate, it delivers long-term symptom control, improves lung function, and enhances quality of life.\n\nWhen used consistently and correctly under medical supervision, this inhalation therapy not only helps manage respiratory symptoms but also reduces the frequency of exacerbations and hospitalizations. For patients seeking dependable relief and sustained respiratory health, Salmeterol and Fluticasone Propionate Inhalation IP remains one of the most trusted and effective therapies available today.", "price": 442.0, "discountamount": 132.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2194, "imageuri": "https://productimages.withfloats.com/actual/6905fe746e096b327485136e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6905fe746e096b327485136e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-01T12:34:56.205Z", "updatedon": "2025-11-04T12:39:23.123Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/salmeterol-and-fluticasone-propionate-inhalation-ip-/2194", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }